Literature DB >> 15266277

Voluntary HIV counseling and testing of pregnant women--an assessment of compliance with Michigan public health statutes.

Paula Schuman1, Theodore B Jones, Suzanne Ohmit, Cynthia Marbury, Marilyn P Laken.   

Abstract

OBJECTIVES: First, to evaluate compliance with Michigan's laws mandating universal, voluntary HIV counseling and testing (VCT) of all pregnant women who provide informed consent (ie, the "opt-out strategy"). Second, to assess the acceptability of and agreement to VCT.
METHODS: Women who delivered a live infant at a large, urban academic medical center were interviewed before hospital discharge. Obstetric and prenatal medical records were abstracted to document that VCT was offered, accepted, or declined and that pre- and posttest counseling were provided and test results noted.
RESULTS: Our survey of 491 postpartum women interviewed from February 1998 through January 1999 revealed that 83% reported that they were offered VCT; of those, 95% reported that they had agreed to testing. Uninsured women were least likely to undergo VCT; no other demographic, social, or behavioral characteristics were associated with VCT. Nor was VCT more likely to occur according to providers' different practice settings (ie, "private" vs publicly funded). Most women reported that they did not find VCT offensive or threatening, although only 49% reported that they felt "very comfortable," refusing testing.
CONCLUSION: These results suggest the opt-out strategy for VCT, as currently practiced in Michigan, can effectively promote the US Public Health Service testing goals. Offering VCT with the understanding that it may be refused without risk is essential. Additional educational interventions about HIV infection during pregnancy and perinatal HIV-transmission interruption were requested by women in our study and should be widely promoted. Given that 95% of women agreed to VCT, mandatory testing without consent is not needed to achieve federal testing benchmarks and seems ethically problematic.

Entities:  

Mesh:

Year:  2004        PMID: 15266277      PMCID: PMC1395799     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


  20 in total

1.  Organizational predictors of prenatal HIV counseling and testing.

Authors:  K A Ethier; R Fox-Tierney; W C Nicholas; K M Salisbury; J R Ickovics
Journal:  Am J Public Health       Date:  2000-09       Impact factor: 9.308

2.  Prenatal discussion of HIV testing and maternal HIV testing--14 states, 1996-1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1999-05-21       Impact factor: 17.586

3.  Routine human immunodeficiency virus infection screening in unregistered and registered inner-city parturients.

Authors:  M K Lindsay; T I Feng; H B Peterson; B A Slade; S Willis; L Klein
Journal:  Obstet Gynecol       Date:  1991-04       Impact factor: 7.661

4.  Implementation of guidelines for HIV counseling and voluntary HIV testing of pregnant women.

Authors:  E Joo; A Carmack; E Garcia-Buñuel; C J Kelly
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

Review 5.  Advances and research directions in the prevention of mother-to-child HIV-1 transmission.

Authors:  L M Mofenson; J A McIntyre
Journal:  Lancet       Date:  2000-06-24       Impact factor: 79.321

6.  Barriers to universal prenatal HIV testing in 4 US locations in 1997.

Authors:  R A Royce; E B Walter; M I Fernandez; T E Wilson; J R Ickovics; R J Simonds
Journal:  Am J Public Health       Date:  2001-05       Impact factor: 9.308

7.  Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates.

Authors:  Gayatri C Jayaraman; Jutta K Preiksaitis; Bryce Larke
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

8.  Determinants of acceptance of routine voluntary human immunodeficiency virus testing in an inner-city prenatal population.

Authors:  M K Lindsay; W Adefris; H B Peterson; H Williams; J Johnson; L Klein
Journal:  Obstet Gynecol       Date:  1991-10       Impact factor: 7.661

9.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

10.  U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-07-07
View more
  4 in total

1.  Pregnancy and other factors associated with higher CD4+ T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002.

Authors:  Linda L Wotring; JoLynn P Montgomery; Eve D Mokotoff; Joseph N Inungu; Norman Markowitz; Lawrence R Crane
Journal:  MedGenMed       Date:  2005-03-15

2.  Disparities in prenatal HIV testing: evidence for improving implementation of CDC screening guidelines.

Authors:  Deborah N Pearlman; Abigail R Averbach; Sally Zierler; Kevin Cranston
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

3.  Voluntary counseling and testing among post-partum women in Botswana.

Authors:  Ibou Thior; Lesego Gabaitiri; Janet Grimes; Roger Shapiro; Shahin Lockman; Soyeon Kim; Poloko Kebaabetswe; Edward Garmey; Monty Montano; Trevor Peter; Su-Yuan Chang; Ric Marlink; Max Essex
Journal:  Patient Educ Couns       Date:  2006-10-09

4.  Prenatal screening for infectious diseases: an analysis of disparities and adherence to policy in California.

Authors:  Lamiya A Sheikh; Clea Sarnquist; Erin Moix Grieb; Barbara Sullivan; Yvonne A Maldonado
Journal:  Matern Child Health J       Date:  2008-04-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.